INTERNATIONAL PATENT: GLENMARK PHARMACEUTICALS LIMITED FILES APPLICATION FOR "A STABLE SOLID ORAL DOSAGE FORM OF DABIGATRAN"

GENEVA, March 9 -- GLENMARK PHARMACEUTICALS LIMITED (B/2, Mahalaxmi Chambers,22 Bhulabhai Desai Road, MaharashtraMumbai 400026) filed a patent application (PCT/IB2024/058498) for "A STABLE SOLID ORAL DOSAGE FORM OF DABIGATRAN" on Sep 01, 2024. With publication no. WO/2025/046547, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DHUPPAD, Ulhas (Glenmark Pharmaceuticals Limited, M-4Taloja MIDC, Taluka Panvel, District Raigad, MaharashtraNavi Mumbai 410208), PAI, Raveendra (Glenmark Pharmaceuticals Limited, M-4Taloja MIDC, Ta...